These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21467080)

  • 21. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
    Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ
    J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
    Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
    Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Definitive radiotherapy for squamous cell carcinoma of the anal canal.
    Rabbani AN; Zlotecki RA; Kirwan J; George TJ; Morris CG; Rout WR; Mendenhall WM
    Am J Clin Oncol; 2010 Feb; 33(1):47-51. PubMed ID: 19704368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
    Tahara M; Minami H; Kawashima M; Kawada K; Mukai H; Sakuraba M; Matsuura K; Ogino T; Hayashi R; Ohtsu A
    Cancer Sci; 2011 Feb; 102(2):419-24. PubMed ID: 21134076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
    Tahara M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Three cases of radiotherapy combined with S-1 and mitomycin C for anal canal squamous cell carcinomas].
    Shiozawa M; Nishimura K; Nonaka T; Yoshii T; Nakayama N; Motohashi O; Takagi S; Nakayama Y; Akaike M
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2941-3. PubMed ID: 21160276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction chemotherapy followed by radiotherapy in the treatment of anal cancer.
    Lee DH; Kim I; Song HH; Jung JY; Kim DY; Lee KW; Kim TY; Heo DS; Bang YJ; Ha SW; Park JG; Kim NK
    Oncol Rep; 2003; 10(1):101-4. PubMed ID: 12469152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The therapeutic results and early and late toxicities of the treatment of anal canal carcinoma by radiotherapy or chemoradiotherapy].
    Sommer K; Brockmann WP; Wiegel T; Krüll A; Hübener KH; Birk S
    Strahlenther Onkol; 1991 Aug; 167(8):445-51. PubMed ID: 1909466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708).
    Kato H; Sato A; Fukuda H; Kagami Y; Udagawa H; Togo A; Ando N; Tanaka O; Shinoda M; Yamana H; Ishikura S
    Jpn J Clin Oncol; 2009 Oct; 39(10):638-43. PubMed ID: 19549720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Squamous cell carcinoma of the anal canal showing complete response after concurrent chemoradiotherapy and S-1 plus mitomycin C - a case report].
    Nakashima S; Kiuchi J; Konishi T; Umehara S; Fukuda K; Fujiyama J; Masuyama M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1858-60. PubMed ID: 25731354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing outcomes of chemoradiation in the management of squamous cell carcinoma of the anal canal.
    McHaffie DR; Kozak KR
    Oncology (Williston Park); 2010 Apr; 24(5):424-7. PubMed ID: 20480741
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
    Edelman S; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):206-11. PubMed ID: 16904522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitomycin-C- or cisplatin-based chemoradiotherapy for anal canal carcinoma: long-term results.
    Olivatto LO; Cabral V; Rosa A; Bezerra M; Santarem E; Fassizoli A; Castro L; Simões JH; Small IA; Ferreira CG
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):490-5. PubMed ID: 20472349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. concomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: phase I-II clinical study.
    Strojan P; Karner K; Smid L; Soba E; Fajdiga I; Jancar B; Anicin A; Budihna M; Zakotnik B
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):365-72. PubMed ID: 18394816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
    Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer.
    Nitori N; Kato Y; Kato A; Deguchi T; Okada A; Kojima M; Kuroda J; Kadomura T; Kubota K; Origuchi N; Fujisaki M; Kitajima M
    Anticancer Res; 2011 Nov; 31(11):3983-9. PubMed ID: 22110231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma].
    Ikeda Y; Tsukuda M; Tanigaki Y; Yabuki K; Mitake D; Ishitoya J
    Gan To Kagaku Ryoho; 2008 May; 35(5):789-92. PubMed ID: 18487914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
    Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.